Explorez tous les épisodes du podcast BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors

What does it really mean to be a CEO, and why does the role feel so different once you’re in the seat?
In this episode, Elaine Hamm, PhD, sits down with James Zanewicz, JD, LLM, RTTP, CEO of Connect, to unpack the realities of leadership at the highest level. James shares what surprised him most about becoming a CEO, the weight of responsibility, and how his perspective on leadership has evolved since stepping into the role. Together, they explore the evolving nature of leadership, the importance of building the right team, and why being a CEO is less about control and more about empowerment. Whether you’re a founder, aspiring executive, or already in the role, this episode offers a grounded look at what it truly takes to succeed as a CEO.
In this episode, you’ll learn:

• Why being a CEO can feel isolating, and how to build the right support system.
• How to navigate decision-making, prioritization, and uncertainty when the stakes are high.
• The importance of team building, self-awareness, and continuous learning in effective leadership.

Tune in to hear real-world CEO insights and learn how to lead with clarity, resilience, and purpose in today’s biotech landscape.
Links:
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Gretel von Son, MBA, Tre Braquet, Petra Stegmann, PhD, Lizbeth Dargi, Daniela Gama, and Rick Valencia.
Learn more about OnWard.
Check out the books The First 90 Days, The New CEO, and The Five Dysfunctions of a Team.
Check out our previous episode on Board Composition.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What does it take to build a podcast that not only shares stories, but actively helps founders grow, connect, and get funded?
In this episode, host Elaine Hamm, PhD, is joined by special guest host James Zanewicz, JD, LLM, RTTP, to discuss the launch of Connect’s new podcast, The Connect Current. Designed to highlight the flow of innovation across San Diego’s ecosystem, the podcast will spotlight entrepreneurs, investors, and leaders across multiple sectors, including biotech, tech, climate, defense, and AI. More than just a content platform, this new show aims to give founders a voice, increase visibility, and create meaningful opportunities for connection and growth.
In this episode, you’ll learn:

• How The Connect Current is designed to amplify entrepreneurs and help them build credibility with investors and partners.
• Why short-form, accessible content can be a powerful tool for storytelling, networking, and fundraising.
• How podcasts can serve as a strategic platform to strengthen ecosystems and connect founders with new opportunities.

Tune in to learn how a well-designed platform can elevate founders, strengthen innovation ecosystems, and create new pathways for collaboration and growth.
Links:
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Tre Braquet and Kylie Hovey.
Learn more about Informuta and Resonate Recordings.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What happens when two distinct innovation ecosystems, one rooted in the Gulf South and the other on the West Coast, come together with a shared goal?
In this episode, host Elaine Hamm, PhD, is joined by special guest host James Zanewicz, JD, LLM, RTTP, for a dynamic conversation on how regions like the Gulf South and the San Diego binational ecosystem can collaborate to accelerate biotech innovation. From cross-border partnerships and shared workforce models to creative approaches for connecting founders, investors, and institutions, this episode explores what real collaboration looks like beyond the buzzword.
In this episode, you’ll learn:

• Why binational and cross-regional models can unlock new opportunities in biotech, from workforce to commercialization.
• How the Gulf South’s culture of collaboration creates a strong foundation for ecosystem growth.
• Practical ways to move from talking about collaboration to actually executing it, including shared events, partnerships, and accountability.

Tune in to learn how intentional collaboration, complementary strengths, and a willingness to act can connect ecosystems and create new opportunities for biotech innovation across regions.
Links:
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Patrick Reed, RTTP.
Learn more about the Alliance for Artificial Intelligence in Healthcare and Bio International.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Biotech is still open for business, but what does it really take to get funded in today’s market?
In this episode, host Elaine Hamm, PhD, is joined by special guest host James Zanewicz, JD, LLM, RTTP, the CEO of Connect, for a candid conversation on the current biotech funding landscape and what founders are up against right now. From longer timelines and more selective investors to the growing importance of relationships, differentiation, and capital strategy, they break down what’s changed for early-stage companies. Drawing from both of their experiences, they explore how founders can navigate today’s environment with sharper focus, stronger storytelling, and a more disciplined approach to execution.
In this episode, you’ll learn:

• Why strong science is no longer enough, and how founders must clearly demonstrate a path to value creation and return on investment.
• How to build a “patchwork” capital strategy across venture, non-dilutive funding, partnerships, and alternative sources.
• What founders should prioritize today, from milestone planning and capital efficiency to operational discipline and relationship building.

Tune in to learn how to navigate a tougher biotech market, position your company for funding, and build a strategy that stands out in an increasingly competitive landscape.
Links:
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What can a 40-year-old innovation organization teach today’s startup ecosystems about staying relevant and driving impact?
In this episode, host Elaine Hamm, PhD, is joined by special guest host James Zanewicz, JD, LLM, RTTP, the original voice behind this podcast and now CEO of Connect in San Diego. James shares insights from stepping into leadership at one of the nation’s most established innovation organizations, reflecting on Connect’s evolution from a hands-on startup support model to a globally recognized ecosystem builder. The conversation explores what it takes to sustain and grow innovation communities over decades, and how lessons from mature ecosystems can inform emerging regions like the Gulf South.
In this episode, you’ll learn:

• Why even the most established innovation organizations must continuously evolve to stay impactful.
• How Connect is positioning itself as a “front door” to help entrepreneurs navigate dense ecosystems.
• What founders actually need from ecosystem support and how to deliver it in practical, actionable ways.

Tune in to learn how leadership, adaptability, and a founder-first mindset can shape the future of innovation ecosystems in both mature and emerging regions.
Links:
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about Cleantech, San Diego Sports Innovators, and Athena.
Connect with Guy Kawasaki, MBA, Petra Stegmann, PhD, and Daniela Gama.
Check out the book The First 90 Days.
Check out our previous episode with Australia’s Alita Singer and David Brown.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What does it really take to build a sustainable biotech ecosystem outside of traditional hubs like Boston and San Francisco?
In this episode, host Elaine Hamm, PhD, is joined by Christin Godale, PhD, Executive Director of LifeSciKY, to explore how regional innovation communities can grow from the ground up. Christin shares how LifeSciKY is helping entrepreneurs access lab space, shared equipment, mentorship, and community support. The conversation dives into the realities of building biotech infrastructure in emerging regions, and why success comes from leaning into local strengths, building partnerships, and creating opportunities for founders to succeed where they are.
In this episode, you’ll learn:

• Why successful biotech ecosystems rely on strong partnerships between government, industry, and academia.
• How regions outside traditional biotech hubs can build sustainable innovation communities by leveraging their unique strengths.
• What incubators and shared lab spaces must provide beyond real estate to truly support founders and early-stage companies.

Tune in to learn how collaborative communities and intentional partnerships can transform regional innovation ecosystems and create new opportunities for biotech entrepreneurship.
Links:
Connect with Christin Godale, PhD, and learn about LifeSciKY.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine, as well as Cadenza Bio.
Learn more about Thermo Fisher Scientific, Project Medtech, and SmartHealth Catalyzer.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Math doesn’t have to be intimidating, especially when it’s the kind that helps fund companies and move science forward.
In this episode, host Elaine Hamm, PhD, is joined by Isaiah Reeves, PhD, Biomedical Analyst at Solas BioVentures, for a practical and approachable deep dive into venture math. Drawing on his background as a scientist turned investor, Isaiah breaks down the core financial concepts every biotech founder should understand: from valuations and dilution to IRR, cap tables, and deal terms. The conversation offers real-world guidance for navigating fundraising, choosing the right partners, and avoiding common pitfalls that can derail long-term value creation.
In this episode, you’ll learn:

• How venture capitalists think about valuations, dilution, and returns, and why fully diluted post-money matters.
• Key metrics like IRR and DPI, and how they influence investment decisions and fund performance.
• Common deal terms and cap table “red flags” founders should watch out for as they raise capital.

Tune in to learn how understanding venture math can help founders make smarter funding decisions, protect long-term value, and build biotech companies positioned for sustainable growth and impact.
Links:
Connect with Isaiah Reeves, PhD, and check out Solas BioVentures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine, as well as Cadenza Bio.
Connect with Josh Eckelberry, MBA, and Mark Corrigan, MD.
Check out the books The Go-Giver and Venture Deals.
Check out the podcasts STAT, Biotech Hangout, and 20VC.
Check out our previous episodes on Networking as an Introvert and Solas BioVentures with Travis Manasco.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Politics can feel overwhelming - but how can scientists, founders, and biotech leaders effectively engage with policymakers to protect innovation and improve patient outcomes?
In this episode, host Elaine Hamm, PhD, is joined by Srinu Sonti, JD, Principal at Lewis-Burke Associates LLC, for a candid and insightful conversation on science, policy, and advocacy. Drawing on his experience on Capitol Hill, in health policy, and working with academic medical centers and startups, Srinu breaks down how innovation, funding, and regulation intersect - and why it’s critical for scientists and biotech leaders to have a voice in the policy process.
In this episode, you’ll learn:

• Why policymakers want to hear directly from scientists, founders, and innovators, and how those conversations shape decisions.
• Practical ways universities, startups, and small teams can engage lawmakers beyond sending emails or reacting to crises.
• How policy choices around clinical trials, AI, global collaboration, and advanced therapies impact patients and the future of biotech.

Tune in to learn how building authentic relationships with policymakers can demystify science, strengthen innovation ecosystems, and help move life-saving technologies from the lab to the people who need them most.
Links:
Connect with Srinu Sonti, JD, and check out Lewis-Burke Associates LLC.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out Pew Charitable Trusts.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Where do scientific breakthroughs really begin, and how much space do we leave for curiosity, intuition, and creative thinking along the way?
In this episode, host Elaine Hamm, PhD, is joined by Auni Williams, PhD, a postdoctoral scholar at Penn State University, for a thoughtful and refreshing conversation about “night science.” Together, they explore the idea that behind every polished grant, publication, or protocol is a messier, more human process driven by curiosity, imagination, and the freedom to explore unconventional ideas. From historical examples of scientific breakthroughs to personal stories from the lab, this episode invites listeners to rethink how discovery really happens.
In this episode, you’ll learn:

• What “night science” is and why embracing early, unpolished ideas is critical for innovation and discovery.
• How modern research culture can unintentionally suppress creativity – and what institutions and leaders can do to protect exploratory thinking.
• Why communicating science as a human, curiosity-driven process is essential for engaging both scientists and the public.

Tune in to learn how making space for curiosity, creativity, and night science can reignite passion for research and lead to the next generation of scientific breakthroughs.
Links:
Connect with Auni Williams, PhD, and learn more about Penn State University.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about François Jacob, Barry Marshall, August Kekulé, Operation Everest, American Heart Association Funding, and Cormac McCarthy's essay.
Listen to our previous episode with Walter Isaacson.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What does it really take to modernize a tech transfer office and build innovation ecosystems that thrive outside the traditional coastal hubs?
In this episode, host Patrick Reed, RTTP, is joined by Robert Lowe, PhD, CEO of TechPipeline, for a timely conversation on how tech transfer offices can evolve in a rapidly changing innovation landscape. From data-driven decision-making and intentional use of AI to workforce development and ecosystem-building beyond the coasts, this episode offers practical insights for university and industry engagement leaders navigating what comes next.
In this episode, you’ll learn:

• Why “perfect is the enemy of good” when modernizing tech transfer systems, and how using the right mix of tools can improve outcomes.
• How tech transfer offices can leverage AI as a force multiplier while maintaining strong foundational skills.
• What smaller and mid-sized cities can do to build collaborative, high-impact tech transfer and startup ecosystems.

Tune in to learn how a data-informed approach to tools, training, and ecosystem strategy can help tech transfer offices accelerate innovation and deliver greater impact wherever they’re located.
Links:
Connect with Robert Lowe, PhD, and check out TechPipeline.
Connect with Patrick Reed, RTTP, and learn about IPX at Auburn University.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How do you build a venture strategy that both delivers strong returns and meaningfully improves the lives of children and families?
In this episode, host Elaine Hamm, PhD, sits down with Andrew Meadow, MBA, Founding Partner and Chief Investment Officer at Health Innovation Capital, for a thoughtful conversation about investing in pediatric and maternal health. Andrew shares the personal and professional journey that led him to focus his career on underserved pediatric populations, and why children are not just “small adults” when it comes to innovation, clinical development, and investment strategy.
In this episode, you’ll learn:

• Why pediatric and maternal health remain some of the most underfunded (and high impact) areas in biotech.
• How venture funds can balance financial returns with real-world improvements in access, affordability, and quality of care.
• What entrepreneurs need to know to engage pediatric-focused investors and stand out in a competitive funding environment.

Tune in to hear how purpose-driven venture capital can change the trajectory of healthcare innovation and why investing in children may be one of the most important bets biotech can make.
Links:
Connect with Andrew Meadow, MBA, and check out Health Innovation Capital.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can biotech teams move faster (and smarter) from preclinical research to human trials without sacrificing safety or rigor?
In this episode, host Elaine Hamm, PhD, sits down with Todd Kilbaugh, MD, Founder of Pharos Biolabs and a physician-scientist specializing in anesthesiology, critical care, and pediatrics. Todd shares his journey from clinical medicine to biotech entrepreneurship and unpacks one of the industry’s toughest challenges: why so many promising therapies fail to translate from animal models to humans. Together, they explore how AI, advanced modeling, organoids, and more thoughtful use of non-human primates could reshape preclinical development and reduce costly failures.
In this episode, you’ll learn:

• Why the translational gap between animal models and humans remains one of biotech’s biggest bottlenecks, and how AI can help close it.
• How biomarkers, mathematical modeling, and digital twins can improve trial design long before a therapy reaches the clinic.
• What the future of preclinical development could look like with smarter integration of AI, organoids, and non-human primate studies.

Tune in for a wide-ranging conversation on AI-enabled science, better trial prediction, and how biotech can rethink the path from discovery to patients.
Links:
Connect with Todd Kilbaugh, MD.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Doug Wallace, PhD.
Learn more about TBI.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Trying to form early biotech partnerships but unsure when to say yes, when to push back, or when to walk away?
In this episode, host Elaine Hamm, PhD, welcomes back Renee Williams, PhD, MBA, returning to the show as Chief Business Officer at Signify Bio. Drawing from her experience on both sides of the table (as a pharma dealmaker and now an early-stage biotech leader) Renee shares hard-earned insights on how founders can approach partnerships strategically without losing focus, time, or control of their company’s story.
In this episode, you’ll learn:

• How to evaluate early partnership opportunities and decide which ones are worth your limited time, capital, and attention.
• Why focus is the most valuable currency for early-stage biotech, especially for platform companies facing constant “what else could this do?” questions.
• Practical guidance on MTAs, pilot studies, and proof-of-concept work, including how to structure collaborations so they move you closer to a real deal—not just more experiments.

Whether you’re navigating your first pharma conversation or refining how you partner as a growing biotech company, this episode offers clear, experience-driven advice to help you build partnerships that accelerate progress instead of distracting from it.
Links:
Connect with Renee Williams, PhD, MBA, and check out Signify Bio.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out our previous episode with Renee.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What’s really happening in biotech right now, and where should innovators and investors be paying attention?
In this market update episode, host Elaine Hamm, PhD, is joined by guest host Travis Manasco, MD, for a candid conversation on the current state of biotech investing. Together, they unpack where momentum is building, where enthusiasm is cooling, and how founders, scientists, and investors should think strategically as the market finds its footing. From GLP-1s and AI to women’s health and preclinical challenges, this episode offers a clear-eyed look at today’s biotech landscape—just in time for JPM.
In this episode, you’ll learn:

• Which biotech sectors are heating up and why areas like obesity, AI-enabled clinical trials, and women’s health are drawing renewed interest
• Why early-stage and preclinical innovation remains a tough funding environment, despite long-term opportunity
• How market signals like acquisitions and JPM dynamics may shape biotech strategy in the year ahead

Tune in for an honest, insightful market conversation that cuts through the hype and helps you think more clearly about where biotech is headed next.
Links:
Connect with Travis Manasco, MD, and check out Solas BioVentures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the JP Morgan Healthcare Conference 2026.
Check out our previous episode with Travis on AI in Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Want to come back from JP Morgan with more than just a stack of business cards?
In this timely episode, host Elaine Hamm, PhD, sits down with Chris Yochim, a longtime JP Morgan Healthcare Conference insider. With more than three decades of experience leading partnering strategy at AstraZeneca and Zeneca, Chris shares a practical, behind-the-scenes look at how the world’s most intense healthcare meeting really works—and how to prepare for it effectively. As JP Morgan approaches, Elaine and Chris break down what “success” looks like for different audiences, from academic tech transfer and startups to investors and large pharma.
In this episode, you’ll learn:

• How to define “winning” at JP Morgan based on your role—academic, startup, investor, or industry leader.
• Why preparation, flexibility, and memorable first impressions matter more than a full calendar of meetings.
• Practical tips for pitching, following up, and building long-term relationships before, during, and after the conference.

Whether this is your first JP Morgan or your tenth, this episode offers actionable advice to help you navigate the chaos, build meaningful connections, and turn conversations into real momentum.
Links:
Check out the JP Morgan Healthcare Conference 2026.
Connect with Chris Yochim and check out NIIMBL and AstraZeneca.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out EBD Group, RESI, and the Guide to JPM'26 app.
Connect with James Zanewicz, JD, LLM, RTTP and Dennis Purcell, MBA.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can universities become powerful engines of innovation, startups, and economic growth—especially in a challenging funding environment?
In this episode, host Elaine Hamm, PhD, sits down with Kimberly Gramm, PhD, MBA, the David & Marion Mussafer Chief Innovation and Entrepreneurship Officer at the Tulane Innovation Institute and Managing Director of Tulane Ventures. Kimberly shares how Tulane is building a comprehensive innovation ecosystem—from early-stage programming and mentorship to venture funding—designed to help researchers, students, and founders translate discovery into real-world impact. Together, they explore what it takes to change institutional culture, scale innovation thoughtfully, and position universities as active investors in the future of biotech and healthcare.
In this episode, you’ll learn:

• How universities can support founders and technologies across every stage of the innovation journey, not just at commercialization.
• Why mentorship, alumni engagement, and listening to stakeholders are critical to building sustainable innovation programs.
• How strategic venture funds and proof-of-concept investments can accelerate biotech spinouts and regional economic growth.

Whether you’re a researcher, founder, or innovation leader, this episode offers a behind-the-scenes look at how universities can step up, take risks, and help innovation thrive—even in uncertain times.
Links:
Connect with Kimberly Gramm, PhD, MBA, and check out Tulane Innovation Institute and Tulane Ventures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out our previous episode with Kimberly.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What if your alumni network could help fuel the next generation of biotech startups?
In this episode, host Elaine Hamm, PhD, sits down with Evan Nicoll, MBA, and Patrick Hernandez of 1834 Ventures, a new investment fund created by Tulane alumni, for founders with Tulane DNA. They share how their alumni-powered model is helping to close regional funding gaps, strengthen emerging biotech ecosystems, and support founders through trust-driven, relationship-first investing. From navigating today’s tough fundraising climate to understanding what really catches an investor’s eye, this conversation offers practical lessons for founders, universities, and anyone building innovation communities.
In this episode, you’ll learn:

• How alumni networks can become powerful engines for venture funding, mentorship, and deal flow.
• What investors are really looking for in early biotech pitches, and why trust, clarity, and curiosity matter more than perfection.
• Why founders should embrace relationship-building over rapid-fire pitching, and how regional markets like Louisiana can attract coastal investors.

Tune in to discover how connection-driven investing is helping shape the next chapter of biotech growth across the Gulf South — and how you can be part of it.
Links:
Connect with Evan Nicoll, MBA, and Patrick Hernandez, and check out 1834 Ventures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out Cadenza Bio and the book The Speed of Trust.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What does the future of biotech look like when curiosity, not competition, leads the way?
In this episode, host Elaine Hamm, PhD, talks with Aziz Abadsafian, MBA, Technology Scout at Nissan Chemical America. Together, they dive into the “edges” of science — the more speculative world of embryology, longevity, and what Aziz calls the true frontier of biotech. Along the way, they explore how curiosity, relationship-building, and “night science” conversations can unlock unexpected opportunities in your career and in the industry.
In this episode, you’ll learn:

• Why the biggest biotech opportunities lie at the extremes – in aging, fertility, longevity, and neurodegeneration.
• How curiosity and genuine relationships lead to better collaborations than transactional networking ever could.
• Practical advice for scientists and students on finding your path, staying inspired, and building a career that aligns with what you’re good at AND what you love.

Tune in for a thoughtful, funny, and wide-ranging conversation about discovery, imagination, and why the future of biotech will always belong to the relentlessly curious.
Links:
Connect with Aziz Abadsafian, MBA, and check out Nissan Chemical America.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out our previous episode with Cain McClary.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can biotech startup founders navigate the intersection of science, technology, and data to build truly durable companies?
In this episode, host Elaine Hamm, PhD, talks with Cain McClary, MD, Founder and Managing Partner of KdT Ventures, a seed-stage venture firm investing at the convergence of science and technology. A Tulane alumnus and “supply chain junkie,” Cain shares how curiosity, data-driven insight, and strategic storytelling can set biotech innovators apart.
In this episode, you’ll learn:

• The biggest mistakes biotech startups make—and how to avoid them.
• Why understanding incentives, storytelling, and systems is key to scaling innovation.
• How AI, data ownership, and new consumer health models are reshaping the future of biotech.

Tune in to discover how KdT Ventures is rethinking biotech investment—and what it takes to turn scientific insight into lasting impact.
Links:
Connect with Cain McClary, MD, and check out KdT Ventures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about PathAI.
Check out our fireside chat with Walter Isaacson.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Are you tired of competition and struggling to find collaborators in biotech?
In this episode, returning host Patrick Reed, RTTP, talks with Christiaan Engstrom, MBA, Founder and CEO of BLPN, a member-led club connecting life science dealmakers with one goal: helping each other succeed. Christiaan shares how BLPN has built a thriving community where collaboration, mentorship, and trust come first — creating opportunities that go far beyond business cards and conference booths.
In this episode, you’ll discover:

• How a simple mantra — “Find Someone to Help. Repeat.” — is reshaping biotech networking.
• Why connection, not competition, is the key to sustainable industry growth.
• How leaders can strengthen regional biotech ecosystems and bring coastal innovation energy inland.

Tune in to learn how genuine collaboration can transform biotech partnerships – and why the most powerful deals start with helping someone else.
Links:
Connect with Christiaan Engstrom, MBA, and check out BLPN.
Connect with Patrick Reed, RTTP, and learn about Auburn University IPX.
Learn about Tulane Medicine Business Development and the School of Medicine.
Connect with James Zanewicz, JD, LLM, RTTP, and Tamika Jackson.
Check out JPM, BioAlabama, and The Beautiful Way Foundation.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What can today’s biotech innovators learn from the greatest thinkers in history?
In this special episode, we’re bringing you a live recording from BIO on the BAYOU featuring a fireside chat between Elaine Hamm, PhD, and Walter Isaacson — renowned biographer of Steve Jobs, Jennifer Doudna, Leonardo da Vinci, Albert Einstein, and other groundbreaking innovators. Together, they explore the power of curiosity, resilience, and imagination in shaping scientific discovery. From the origins of creativity to the ethical challenges of AI and gene editing, this conversation shines a light on the shared traits that drive humanity’s boldest breakthroughs.
In this episode, you’ll learn:

• Why history’s greatest innovators were powered by relentless curiosity — not just intellect.
• What resilience looks like across centuries, from Leonardo da Vinci to modern-day misfits shaping the future.
• How scientists, universities, and the public can rebuild trust, communicate science better, and rekindle a shared sense of wonder.

Tune in for an inspiring conversation that blends science, storytelling, and the timeless human drive to explore the unknown — straight from the BIO on the BAYOU stage.
Links:
Connect with Walter Isaacson and check out his new book The Greatest Sentence Ever Written.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Does networking stress you out? Are you having difficulty connecting with colleagues at conferences or partnering events?
Mastering the art of genuine connection is essential to advancing your career and building your network. In this listener-favorite episode, James Zanewicz, JD, LLM, RTTP, and Elaine Hamm, PhD, dive deep into their personal strategies for networking success. With years of experience attending and producing biotech events, they share invaluable tips, insights, and even some humorous stories about their networking journeys—both the wins and the awkward moments. Whether you're an introvert looking for practical tips to step out of your comfort zone or an extrovert wanting to refine your approach, this episode offers something for everyone.
In this episode, you'll discover:

• How to approach networking with authenticity, whether you're an introvert or extrovert.
• Tips on building genuine connections at biotech events and staying in touch after.
• Practical rules to position yourself to get the most out of networking, even if it's outside your comfort zone.

Tune in to learn how to connect authentically, overcome social anxiety, and make the most out of your next networking opportunity.
Links:
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn about James’ first communications role: EXTRA!
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

From escaping Communist Romania to pioneering telemedicine in maternal health, this story redefines what it means to lead with purpose.
In this episode, host Elaine Hamm, PhD, sits down with Luissa Kiprono, DO, MBS, MBA, FACOG, CEO Physician and Founder of World Gateway Perinatal Consultants and TeleMed MFM, as well as author of “Push, Then Breathe: Trauma, Triumph, and the Making of an American Doctor.” Dr. Kiprono shares her extraordinary path – from escaping Communist Romania to becoming an Air Force officer and a high-risk pregnancy specialist – and how she’s reshaping women’s health through virtual care.
In this episode, you’ll learn:

• How Dr. Kiprono defines true resilience and how it shaped her life and leadership.
• The power of telemedicine to eliminate barriers to care for pregnant women in rural and underserved communities.
• How to rebuild trust between doctors and patients in the US.

Tune in to hear how Dr. Luissa Kiprono is transforming both maternal care and the meaning of resilience for women everywhere.
Links:
Connect with Luissa Kiprono, DO, MBS, MBA, FACOG, and check out TeleMed MFM and her book Push, Then Breathe: Trauma, Triumph, and the Making of an American Doctor.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU happening RIGHT NOW in New Orleans!
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What if drug development could be faster, more efficient, and centered on what matters most to patients?
In this episode, host Elaine Hamm, PhD, sits down with Klaus Romero, MD, CEO of the Critical Path Institute (C-Path), to explore how two decades of global collaboration have reshaped the way we bring new medicines to life. From redefining clinical endpoints to accelerating treatments for complex diseases like Alzheimer’s and tuberculosis, C-Path is leading a movement to remove bottlenecks in drug development through data, regulatory science, and partnership.
In this episode, you’ll discover:

• How C-Path’s collaborative model helps de-risk and speed up the drug development process.
• Why patient-focused science is so essential for meaningful innovation.
• How data sharing, trust-building, and regulatory transparency drive real-world impact.

Tune in to learn how C-Path is bridging science, regulation, and patient need—transforming the future of drug development through collaboration.
Links:
Connect with Klaus Romero, MD, and check out Critical Path Institute.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about Cadenza Bio and the FDA's Critical Path Initiative.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Is the future of biotech innovation at risk because of workforce shortages?
In this episode, host Elaine Hamm, PhD, talks with Van Ton-Quinlivan, MBA, CEO of Futuro Health and host of the WorkforceRx podcast, about how the biotech and healthcare industries can overcome the growing workforce crisis. Together, they explore how intentional workforce development, stackable credentials, and stronger partnerships between industry and education can help close the talent gap and create a more diverse, sustainable pipeline of healthcare professionals.
In this episode, you’ll discover:

• Why workforce shortages—not funding—may be the biggest threat to healthcare innovation.
• How stackable credentials and education partnerships can expand access to biotech and allied health careers.
• Strategies for building a diverse and future-ready workforce that keeps innovation moving forward.

Tune in to hear how biotech and healthcare leaders can tackle the talent crisis head-on and build a stronger, more resilient future for innovation.
Links:
Connect with Van Ton-Quinlivan, MBA, and check out Futuro Health and the WorkforceRx podcast.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the California Health Workforce Education and Training Council, Genentech, Kaiser Permanente, and NextFlex.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What if preventing hearing loss could also help prevent dementia and other aging-related diseases?
In this episode, host Elaine Hamm, PhD, speaks with Celia Belline, Co-Founder and CEO of Cilcare, a biotech company pioneering therapies and analytics for hearing disorders. Celia shares how her company evolved from early research roots into a global leader tackling the connection between auditory health and cognitive decline. From building a business in a niche market to striking a major partnership with Shionogi, she reveals what it takes to innovate in an underexplored — yet crucial — area of biotech.
In this episode, you'll learn:

• How hearing loss research offers powerful insights into preventing dementia and other neurodegenerative diseases.
• Why Cilcare built a unique three-part model combining external innovation, therapeutics, and auditory analytics.
• Lessons from taking bold risks in an emerging field — and advice for founders on building partnerships that last.

Tune in to discover how addressing hearing loss today could change the future of aging and brain health.
Links:
Connect with Celia Belline and check out Cilcare.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Sylvie Pucheu, PhD, and Marie-Pierre Pasdelou, PharmD, the other co-founders of Cilcare.
Check out Sanofi and Shionogi.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What makes the Gulf South one of the most exciting—and overlooked—regions for biotech innovation?
In this special episode, Elaine Hamm, PhD (Tulane Medicine), Patrick Reed, RTTP (Auburn University), and Marcus Brown, PhD (LSU Health) come together to explore the origins, growth, and future of BIO on the BAYOU, the preeminent event showcasing biotech across the Gulf South. From its beginnings as a collaboration between Tulane and LSU, to its expansion into a regional destination that attracts universities, startups, investors, and global partners, this conversation dives into why BIO on the BAYOU has become a must-attend for biotech leaders (returning October 28 & 29, 2025).
In this episode, you’ll learn:

• How BIO on the BAYOU grew from a local idea to a marquee conference drawing national and international attention.
• Why the Gulf South’s overlooked science, startups, and universities are finding their spotlight through this event.
• The unique mix of panels, pitches, partnering, and New Orleans-style networking that sets BIO on the BAYOU apart.

Whether you’re a startup founder, an investor, or simply curious about the future of Gulf South biotech, this episode gives you a front-row seat to the story behind BIO on the BAYOU 2025.
Links:
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Patrick Reed, RTTP, and learn about Auburn University.
Connect with Marcus Brown, PhD, MBA, and learn about LSU Health New Orleans.
Check out the New Orleans BioInnovation Center (NOBIC) and check out their BioChallenge 2025.
Check out The Bullpen and PartneringONE.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can we fix a healthcare system that has too often overlooked women?
In this episode, host Elaine Hamm, PhD, speaks with Georgie Kovacs, MBA, Founder and CEO of Fempower Health, about her mission to empower women through evidence-based information and community support. Georgie shares her journey from personal experience with endometriosis to building a trusted platform that connects women with leading experts. Together, Elaine and Georgie dig into the history—and ongoing challenges—of women’s inclusion in clinical trials, the gaps in data that still shape care today, and why patient advocacy and systemic change are more critical than ever.
In this episode, you’ll learn:

• Why women were historically excluded from clinical trials—and the consequences still felt today.
• How patient advocacy, informed consent, and inclusion can reshape women’s healthcare.
• What biotech leaders, clinicians, and investors must consider when designing studies and funding women’s health innovations.

Tune in to hear Georgie’s vision for transforming women’s health from fragmented care into informed, empowered, and equitable solutions.
Links:
Connect with Georgie Kovacs, MBA, and check out Fempower Health.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the Endometriosis Working Group and take the survey.
Learn more about the Tulane Center of Excellence in Sex-Based Precision Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How do you turn world-class science into sustainable biotech companies that grow both patients’ futures and local economies?
In this episode, host James Zanewicz, JD, LLM, RTTP, speaks with Dave Ousterout, PhD, Co-Founder and General Partner of Cape Fear BioCapital. Drawing from his journey as a biotech entrepreneur and now investor, Dave shares how his team is working to transform North Carolina’s biotech ecosystem—filling funding gaps, building strong teams, and helping startups move from promising science to impactful medicines.
In this episode, you’ll discover:

• The key lessons Dave learned as a biotech founder and how they shape his investment strategy today.
• Why Cape Fear BioCapital focuses on “building, not just picking” companies in North Carolina.
• What investors want to see from early-stage biotech startups and how founders can prepare to meet those expectations.

Tune in to learn how Cape Fear BioCapital is fueling innovation and what biotech leaders everywhere can take away from their approach.
Links:
Connect with Dave Ousterout, PhD, and check out Cape Fear BioCapital.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ed Field, MBA, Jimmy Melton, MHA, and Paul Garofolo.
Learn more about Locus Biosciences, Inceptor Bio, Moore Strategic Ventures, G1 Therapeutics, Thoracic Innovations, TEN63 Therapeutics, and Boehringer Ingelheim.
Listen to our previous episode with Travis Manasco.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What do biotech boards want to see in a CEO—and what mistakes can quickly derail a company’s success?
In this episode, host Elaine Hamm, PhD, sits down with Mark Corrigan, MD, one of the most experienced and respected leaders in the biotech industry. From shaping the development of blockbuster drugs to serving as CEO and board member for multiple companies, Mark has a unique perspective on the intersection of science, leadership, and strategy. He shares candid insights on what makes a strong CEO, the role boards should (and shouldn’t) play, and how to navigate today’s tough financing environment without losing sight of the mission.
In this episode, you’ll learn:

• The key qualities that boards value most in biotech CEOs—and the red flags that raise concerns.
• Why humility, adaptability, and a clear value proposition are essential traits for leadership.
• How boards and CEOs can partner effectively when money is tight and timelines are long.

Tune in to gain board-level insights into biotech leadership and decision-making that can help you shape your own path forward.
Links:
Connect with Mark Corrigan, MD, and check out Wave Life Sciences, AstronauTx, Silver Creek Pharmaceuticals, Ceretype Neuromedicine, and Cadenza Bio.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Listen to our previous episode on Building Biotech Boards.
Check out The California Honeydrops and Willamette Valley Pinot.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can healthcare investment banking put patients—not just profits—at the center of biotech deals?
In this episode, host James Zanewicz, JD, LLM, RTTP, speaks with Sam Libby, President and Managing Director of TCB Capital Advisors. Drawing from more than $20 billion in transactions across therapeutics, diagnostics, and digital health, Sam explains how TCB’s unique advisory model partners with companies before and after deals close. From growing up with therapist parents to founding a merchant bank, Sam shares how personal values and professional experience can come together to shape smarter strategies for healthcare innovation.
In this episode, you’ll learn:

• Why patient-centered thinking belongs at the core of investment strategy.
• Common mistakes healthcare startups make when pitching to investors—and how to avoid them.
• The critical role of clinical data, mission alignment, and timing in building sustainable biotech companies.

Tune in to learn how to navigate healthcare investments with purpose and ensure your biotech mission makes a lasting impact.
Links:
Connect with Sam Libby, and check out TCB Capital Advisors.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about Clairity and Informuta.
Listen to our previous episode on Drug Pricing and Accessibility.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can biotech leaders navigate the complexities of neurodegenerative research while tackling today’s funding challenges?
In this episode, host Elaine Hamm, PhD, welcomes Vikas Sharma, PhD, Chief Business Officer at QurAlis, for an insightful conversation on innovation, leadership, and fundraising in the biotech sector. Drawing from his extensive experience with ALS and neurodegeneration research, Vikas shares lessons on balancing science with business, navigating board dynamics, and finding creative approaches to raise capital.
In this episode, you’ll discover:

• Why genetic insights are reshaping neurodegenerative research.
• How to creatively approach funding when investors are focused on lower-risk, later-stage opportunities.
• Practical strategies for balancing science, investors, and board relationships to drive biotech success.

Tune in to gain actionable strategies and leadership lessons that can help you move your biotech forward with confidence.
Links:
Connect with Vikas Sharma, PhD, and check out QurAlis.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Jason Adair, MBA, and Kevin Eggan, PhD.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How did a podcast that started as a simple experiment become a trusted voice in biotech conversations?
In this special 100th episode, co-hosts Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, take a step back to reflect on the BIO from the BAYOU journey. From the early days of experimenting with format to connecting with some of the most influential voices in biotech, they share behind-the-scenes stories, lessons learned, and how the podcast has evolved into a platform that bridges science, business, and storytelling.
In this episode, you’ll hear:

• The origins of BIO from the BAYOU and how it found its unique voice in the biotech landscape.
• Memorable moments, favorite guest insights, and the biggest lessons learned over 100 episodes.
• A look ahead at what’s next for the podcast — including an exciting update from James at the end of the episode.

Join us in celebrating 100 episodes of conversation, connection, and community in biotech — and get ready for what’s to come!
Links:
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with other hosts Patrick Reed, RTTP, Sharon Courtney, Nicole Honoree, RTTP, Kaneisha Akinpelumi, and Carolyn Scofield, MPS.
Connect with Adam Goodcoff, DO, Neil Greene, Tari Suprapto, PhD, James McLachlan, PhD, Travis Manasco, MD, Mike Rondelli, JD, MBA, Tre Braquet, Kylie Hovey, and Lee Hamm, MD.
Learn more about Connect, The Study, and EXTRA!
Listen to our previous episodes mentioned - linked here.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Can artificial intelligence map your heart and help prevent strokes, dementia, and even death from cardiac arrhythmias?
In this episode, host Elaine Hamm, PhD, talks with Rob Krummen, JD, CEO of Vektor Medical, and Travis Manasco, MD, Principal at Solas BioVentures, about how AI is changing the game for diagnosing and treating heart rhythm disorders. They share how Vektor’s vMap technology — the “Google map of your heart” — pinpoints arrhythmia sources using standard EKGs, fitting seamlessly into existing clinical workflows. The conversation also dives into what investors look for in AI-driven health innovations and how startups can stand out in a crowded field.
In this episode, you’ll learn:

• Why cardiac arrhythmias are more common — and more deadly — than most people realize.
• How vMap’s AI-driven insights can improve outcomes, reduce repeat procedures, and expand care to rural hospitals.
• The key elements investors want to see in AI healthcare pitches, from workflow integration to reimbursement strategy.

If you’re interested in AI in medicine, medtech innovation, or how to pitch to venture capital, this episode delivers valuable lessons straight from the front lines of clinical care and investment.
Links:
Connect with Rob Krummen, JD, and check out Vektor Medical.
Connect with friend of the show Travis Manasco, MD, and check out Solas BioVentures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with vMap inventor David Krummen, MD, and Solas BioVentures co-founder David Adair, MD, MBA.
Listen to our previous episode with Travis on Crafting a Pitch That Attracts Venture Capital.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can biotech companies stay resilient and competitive when public sector funding becomes unpredictable?
In this episode, host James Zanewicz, JD, LLM, RTTP, sits down with Adeyinka “Adey” Pierce-Watkins, MS, PMP—Director of Biodefense and Government Contracting at BDO USA—for a timely conversation on surviving and thriving in today’s evolving federal funding landscape. From defense contracts to international partnerships, Adey shares practical guidance for life science leaders aiming to tap into strategic public funding opportunities.
In this episode, you’ll learn:

• How to identify and access alternative funding sources—including state, federal, and international opportunities.
• What biotech organizations need in place to be “government-ready” for grants, contracts, and urgent response funding.
• Why strategic planning, partnerships, and compliance infrastructure are essential to winning and executing federal awards.

Whether you’re pursuing BARDA grants, entering international consortia, or rethinking your risk exposure, this episode offers actionable insights to help biotech innovators chart a smarter path forward.
Links:
Connect with Adey Pierce, MS, PMP, and check out BDO USA.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about the Cancer Prevention & Research Institute of Texas, TEDCO, and the California Institute for Regenerative Medicine.
Learn more about Flagship Pioneering, Andreessen Horowitz, Novartis, Johnson & Johnson, and Roche.
Learn more about HERA, Horizon Europe, AMED, and A*STAR.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What does it really take to land a successful biotech partnership—and what makes a deal fall apart?
In this episode, host Elaine Hamm, PhD, sits down with Renee Williams, PhD, MBA, Founder and Managing Partner of Williams Biotech Consulting and Independent Board Director for AGS Therapeutics. With experience across major pharma companies like Eli Lilly and Janssen, Renee shares hard-earned insights from the front lines of dealmaking. From communication missteps to finding the right partner, she explains how to navigate biotech partnerships with clarity, confidence, and strategy.
In this episode, you’ll learn:

• Why overcommunication is key to every stage of the deal process.
• How to identify (and avoid) red flags in strategic partnerships.
• What scientists need to know to transition into biotech business roles.

Whether you’re negotiating a licensing deal or dreaming of your first exit, this episode is packed with advice you won’t want to miss.
Links:
Connect with Renee Williams, PhD, MBA, and check out Williams Biotech Consulting and AGS Therapeutics.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about Eli Lilly and Janssen Pharmaceutical.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What happens when patients can’t afford the medicine you’ve worked so hard to create?
In this episode, host Elaine Hamm, PhD, sits down with Vinay Patel, PharmD—Chief Pharmacy Officer at Proactive MD and Founder of MakoRx—to unpack the hidden complexities behind drug pricing, access, and affordability. Together, they explore how traditional insurance models impact patient care, and what drug developers and startups need to know to ensure their therapeutics actually reach the people who need them.
In this episode, you’ll discover:

• Why pharmacy benefit managers (PBMs) influence drug access—and what that means for your commercialization strategy.
• How cost-plus pricing models are changing the healthcare landscape.
• Key considerations for biotech innovators to ensure affordability, patient access, and long-term success.

Whether you're developing a new therapeutic or trying to understand the real-world implications of drug pricing, this conversation offers a powerful look behind the pharmacy counter.
Links:
Connect with Vinay Patel, PharmD, and check out Proactive MD and MakoRx.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about The Study, Elaine’s wine bar.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.

Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Wondering how to stand out in the crowded biotech world and build credibility that opens doors?
In this episode, hosts Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, explore the power of personal branding for biotech professionals. Whether you’re a startup founder, academic researcher, or key opinion leader, your brand can shape your career, attract collaborators, and grow your influence. With real-world stories, practical tools, and some laughs along the way, Elaine and James break down how to craft and share a brand that’s both authentic and impactful.
In this episode, you’ll learn:

• How to define your value proposition and align your voice with your mission.
• Tips for building an authentic online presence and using platforms like LinkedIn effectively.
• Why your personal brand is key to trust, visibility, and long-term leadership in biotech.

If you’re ready to build your reputation, expand your network, and become a go-to expert in your space—this episode is for you.
Links:
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Jane Muir, RTTP, James McLachlan, PhD, Lisa Morici, PhD, Heddwen Brooks, PhD, Sarah Lindsey, PhD, and Ashley Stahl.
Learn more about The Five Dysfunctions of a Team, You Turn, and EXTRA!
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Are you ready to pitch your biotech startup to investors but unsure what they’re actually looking for?
In this episode, host James Zanewicz, JD, LLM, RTTP, sits down with Travis Manasco, MD — Principal at Solas BioVentures, practicing ICU physician, and Tulane alumnus — for a clear-eyed look at what it takes to secure life science venture capital. From communicating clearly to avoiding common missteps, Travis offers practical advice that every founder should hear before stepping into a pitch meeting.
In this episode, you’ll discover:

• The "goat, moat, float, and dote" framework Solas uses to evaluate investments.
• What makes an investor-ready pitch — and why focus matters more than ambition.
• How founders can build lasting relationships with VCs and avoid first-call deal-killers.

Whether you're refining your deck or just starting your fundraising journey, this episode is packed with actionable insights to move your biotech forward.
Links:
Connect with Travis Manasco, MD, and check out Solas BioVentures.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Penelope Manasco, MD, Elizabeth Chabe, MBA, Tari Suprapto, PhD, and David Adair, MD, MBA.
Learn more about Francis Medical, I-O Urology, Vektor Medical, and OpenEvidence.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.

Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Bridging the gap between academia and industry isn’t easy—but it’s essential for innovation.
In this episode, hosts Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, explore how biotech startups and academic institutions can break down silos and build stronger partnerships. From shared resources and mutual funding opportunities to culture shifts and advisory support, they reveal how deeper engagement between innovation hubs and industry players can lead to better science, better business, and better outcomes.
In this episode, you’ll learn:

• Why understanding each other’s goals and processes is key to successful startup–university collaborations.
• How universities can help startups find funding, credibility, and critical talent—and what startups offer in return.
• Actionable tips for building long-term, win-win partnerships that drive innovation forward.

Whether you’re spinning out of a lab or investing in university research, this episode will give you new strategies to connect and collaborate with purpose.
Links:
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development, the School of Medicine, and the National Primate Research Center.
Connect with Katie Acuff, JD, MBA, Lauren Jardell, and Ellen Palmintier, JD, RN.
Tune in to our previous episode on Boards of Directors and Scientific Advisory Boards.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025. And click here to apply for a startup pitch slot.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Are you a biotech leader battling overload, stress, or even burnout?
In this episode, co-hosts James Zanewicz, JD, LLM, RTTP, and Elaine Hamm, PhD, sit down with returning guest Carlo Odicino, MBA, founder and CEO of One Team Partners, for a powerful and realistic discussion about navigating the pressures of leadership in a high-stakes industry. From battling overwhelming priorities to preserving your health and well-being while growing your business, Carlo offers hard-won strategies for turning chaos into calm and turning pressure into progress.
In this episode, you’ll discover:

• The most common contributors to burnout for CEOs – and strategies to avoid them.
• Why self-care and delegation are essential for strong, sustainable leadership.
• How routines, healthy habits, and re-framing your choices can enable you to withstand stress and keep innovating.

Get ready to lead with clarity, keep your cool, and chart a path forward—no matter what the market throws at you.
Links:
Connect with Carlo Odicino, MBA, and check out One Team Partners.
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025. And click here to apply for a startup pitch slot.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Is your biotech startup feeling the squeeze of a tough funding environment?
In this episode, hosts Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, have a candid, advice-packed discussion about how biotech founders can manage funding challenges, extend runway, and stay resilient when capital is tight. With practical examples and hard-earned insights, they explore strategies for leading lean teams, strengthening investor relationships, and building scrappy collaborations that move innovation forward—even in difficult times.
In this episode, you’ll learn:

• How to build resilience and make smart trade-offs when resources are limited.
• The importance of transparency, adaptability, and mission-driven decision-making.
• Why now may be the best time to build partnerships, strengthen investor relations, and refocus on what matters most.

Get ready to lead with clarity, keep your cool, and chart a path forward—no matter what the market throws at you.
Links:
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about Maykr, as well as The Study, Elaine’s wine bar.
Check out previous episodes on Mastering Resilience and Building a Scientific Advisory Board and Board of Directors.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025. And click here to apply for a startup pitch slot.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

What if the culture you’re building is quietly holding back top talent?
In this episode, hosts Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, sit down with Carlo Odicino, MBA—Founder and CEO of One Team Partners—to explore how unconscious gender bias affects team dynamics, pay equity, and innovation in biotech startups. Drawing from his experience working with high-growth companies, Carlo shares real-world insights and practical tools for identifying bias and fostering intentional, inclusive workplace cultures.
In this episode, you’ll discover:

• How unconscious bias manifests in hiring, performance reviews, and leadership interactions.
• Strategies startups can use to identify pay gaps, support equitable leadership, and create feedback-safe environments.
• Why inclusive culture isn’t a “later” priority—and how getting it right early can reduce turnover and accelerate growth.

From subtle labels like “bossy” to structural decisions that perpetuate inequity, this episode offers clear-eyed advice for founders and executives ready to build better biotech companies.
Links:
Connect with Carlo Odicino, MBA, and check out One Team Partners.
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Are you ready to make the most of your time at BIO 2025?
In this episode, hosts Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, break down everything biotech leaders need to know about the spring conference season and how to strategically prepare for the BIO International Convention in Boston this June. From building long-term relationships and mastering partnering systems to smart use of AI and personal branding, they cover the real-world tips that will help you turn conversations into collaborations.
In this episode, you’ll discover:

• What spring conferences revealed about current biotech funding trends—and how to adapt.
• How to prep for BIO 2025 like a pro, from building meeting packets to using AI to streamline follow-up.
• The overlooked value of sessions, receptions, and personal branding for biotech success.

Whether you're heading to BIO for the first time or you're a seasoned conference veteran, this episode is packed with practical advice to help you stand out and connect.
Links:
Connect with Elaine Hamm, PhD, and James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the conferences: JPM, BIO CEO & Investor Forum, BIO Europe, BioTrinity, and BIO International.
Connect with Alexis Ducote, PhD, Carolyn Scofield, MPS, Kimberly Gramm, PhD, MBA, Tari Suprapto, PhD, Bruce Booth, PhD, and Carol Curtis, PhD.
Learn more about Cadenza Bio, Otologic Pharmaceutics, Maykr, and The Bullpen.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Are you a healthcare professional looking to level up your social media presence—and make a real difference doing it?
In this episode, host James Zanewicz, JD, LLM, RTTP, is joined by Adam Goodcoff, DO, the CEO of MedFluencers and a nationally recognized medical content creator. They dive into the new Healthcare Social Media Academy (developed in collaboration with Tulane Medicine), a program designed to help clinicians learn how to communicate clearly, effectively, and responsibly in the digital space. From shaping public perception of healthcare to combating misinformation and reaching new audiences, this episode breaks down how social media can become a vital tool for education and advocacy.
In this episode, you’ll discover:

• Why healthcare professionals are uniquely positioned to lead online education and how to do it responsibly.
• What the Healthcare Social Media Academy teaches, from content creation to wellness to combatting misinformation.
• The real-world impact of medical social media—including how patient trust is built and broken online.

Whether you’re a digital native or just social media curious, this episode will inspire you to step into the space with confidence, clarity, and purpose.
Links:
Connect with Adam Goodcoff, DO, and check out MedFluencers.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Josh Opitz, co-founder of MedFluencers.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can biotech companies grow faster, smarter, and more sustainably in a turbulent market?
In this episode, host Elaine Hamm, PhD, welcomes Katrina Rogers, CEO of Katrina Rogers Consulting, for a deep dive into the operational and regulatory strategies that help biotech companies succeed—without sacrificing speed, quality, or sanity. With over 25 years of experience in drug development, manufacturing, and quality systems, Katrina offers practical, actionable advice for startups navigating everything from FDA engagement to workforce development and standard operating procedure (SOP) creation.
In this episode, you’ll learn:

• What biotech founders need to know about recent shifts in federal innovation funding and FDA operations.
• How to attract, retain, and empower technical talent—without getting trapped in outdated hiring models.
• Why starting early with documentation and SOPs can save your startup from future chaos.

Whether you’re scaling up or just getting started, tune in for expert insights that can help you build smarter, grow stronger, and stay resilient in today’s evolving biotech ecosystem.
Links:
Connect with Katrina Rogers and check out Katrina Rogers Consulting and The Bullpen.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about the Biotechnology Aptitude and Competency Exam.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can public-private partnerships accelerate your biotech company’s success?
In this episode, host James Zanewicz, JD, LLM, RTTP, welcomes back Elizabeth Chabe, MBA—CEO of High Touch Group—for a deep dive into public-private partnerships (PPPs) and their untapped potential in the biotech sector. Together, they unpack how startups can strategically collaborate with public agencies and institutions, align on shared goals, and build milestone-driven programs that de-risk innovation while driving growth.
In this episode, you’ll learn:

• How public-private partnerships can help biotech startups overcome early-stage hurdles.
• What public funders are really looking for—and how to match their timelines and incentives.
• Practical tips for positioning your startup as a ready and reliable partner.

Tune in to discover how aligning with the right public partner can unlock new opportunities for your biotech venture.
Links:
Connect with Elizabeth Chabe, MBA, and check out High Touch Group and her book, The Giant's Ladder.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ashley Stahl and Elaine Hamm, PhD.
Check out our first episode with Elizabeth: Find Funding for Your Biotech Startup - What Investors Look For.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Trying to turn your scientific breakthrough into a biotech company, but not sure where to start or how to fund it?
In this episode, host Elaine Hamm, PhD, welcomes Zizi Imatorbhebhe, MBA, CEO and Managing Partner at BIOS Health Group, to unpack what it really takes to bring biotech innovations to market. From capital strategy to fractional executive support, Zizi shares practical advice for entrepreneurs navigating today's challenging landscape—and introduces the BIOS Innovation Circle, a venture ecosystem built to support early-stage biotech companies without taking equity.
In this episode, you’ll discover:

• The biggest roadblocks biotech founders face in today’s investment climate—and how to overcome them.
• How BIOS Health Group supports startups with pitch refinement, regulatory strategy, and fractional leadership.
• What the BIOS Innovation Circle is, how it works, and what makes a company a good fit.

Whether you're a scientist with an idea, a startup founder seeking support, or part of a tech transfer team, this episode will help you stop going it alone—and start building your path forward.
Links:
Connect with Zizi Imatorbhebhe, MBA, and check out BIOS Health Group and the BIOS Innovation Circle.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Struggling to raise capital for your biotech startup? Wondering how to communicate your breakthrough to investors who don’t speak your language?
In this episode, host James Zanewicz, JD, LLM, RTTP, is joined by Elizabeth Chabe, MBA, CEO of High Touch Group and author of The Giant’s Ladder. With decades of experience guiding science and engineering companies, Elizabeth shares what it really takes to fundraise successfully in biotech—from building investor-ready strategies to telling your story in a way that gets noticed.
In this episode, you’ll discover:

• The top investor “green flags” biotech startups should prioritize to attract funding.
• How to communicate complex scientific innovations in a way investors will understand and act on.
• Why global thinking and regulatory strategy are essential to raising capital in today’s market.

Whether you’re gearing up for a pre-seed round or planning your exit strategy, this episode will leave you with actionable insights to turn your innovation into impact.
Links:
Connect with Elizabeth Chabe, MBA, and check out High Touch Group and her book, The Giant's Ladder.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Carolyn Scofield, MPS, and Kimberly Gramm, PhD, MBA.
Check out The Bullpen.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

How can you build better partnerships and make the most of your time at biotech events?
In this episode, host James Zanewicz, JD, LLM, RTTP, explores the essentials of successful partnering in the biotech sector with insights from Jordan Stillman, Project Manager of Partnering Services at EBD Group. They dive into partneringONE, EBD Group’s powerful partnering platform, and how it can transform your approach to networking, meeting management, and deal-making.
In this episode, you’ll discover:

• Why partnering is critical for biotech growth and investor engagement.
• How to craft a compelling partnering profile that attracts the right connections.
• Tools and strategies for managing multiple meetings effectively – plus the benefits of partneringONE plus.

Tune in to learn how to streamline your biotech collaborations and maximize your impact at partnering events.
Links:
Connect with Jordan Stillman and learn about EBD Group and partneringONE.
Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.
Check out Episode 49: Optimizing Interactions with Corporate Biotech Companies, featuring Key Opinion Leader Tari Suprapto.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.